1986
DOI: 10.1007/bf00270659
|View full text |Cite
|
Sign up to set email alerts
|

HLA antigens and gold toxicity in American blacks with rheumatoid arthritis

Abstract: An increase in the frequency of DR3 in rheumatoid arthritis (RA) patients exhibiting toxic reactions to gold salt (GS) therapy has been observed in several studies of Caucasoid patients. Likewise, the association of B35 with gold-induced mucocutaneous reactions has also been reported in Caucasoid RA patients. Similar studies in other ethnic groups have not been previously documented. The present study was performed in American black RA patients receiving GS to determine if there were similar HLA associations w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

1989
1989
2010
2010

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 18 publications
0
7
0
Order By: Relevance
“…Cid et a1 (18) confirmed that, in Spanish patients with biops y-proven GCA, DR4 is mainly associated with PMR. The incidence of GCA and/or PMR has been shown to be low in blacks (26), paralleling the low frequency of HLA-DR4 observed in this population (27). Interestingly, there is a corresponding low incidence of PMR and GCA coupled with a low incidence of DR4 in the general population (range 12-14% [19,20]) in northern Italy.…”
Section: Discussionmentioning
confidence: 80%
“…Cid et a1 (18) confirmed that, in Spanish patients with biops y-proven GCA, DR4 is mainly associated with PMR. The incidence of GCA and/or PMR has been shown to be low in blacks (26), paralleling the low frequency of HLA-DR4 observed in this population (27). Interestingly, there is a corresponding low incidence of PMR and GCA coupled with a low incidence of DR4 in the general population (range 12-14% [19,20]) in northern Italy.…”
Section: Discussionmentioning
confidence: 80%
“…RA progression has been extensively examined in many ethnic groups, with the exception of the African American population. This population, often underrepresented in both observational studies and randomized clinical trials, needs to be evaluated in order to understand the disease course and the potential presence of ethnic‐specific risk factors (6–9). To date, there have been few descriptions of the clinical features of RA in this racial/ethnic group.…”
Section: Introductionmentioning
confidence: 99%
“…This study may improve our understanding of the disease course in these patients and possibly help to identify the presence of ethnic-specific risk factors [19-22]. …”
Section: Introductionmentioning
confidence: 99%